Genetics study for Charcot-Marie-Tooth disease
Part of Brain & nervous system, Genetic & congenital clinical trials.
This study looks at genes linked to Charcot-Marie-Tooth disease (CMT), a condition that affects nerves in the arms and legs. It aims to find new causes and understand why symptoms vary. If you join, you may give a blood or saliva sample for genetic testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have neuropathy (nerve damage) shown by nerve tests or a doctor's diagnosis of hereditary neuropathy.
- Or you are a family member of a person with CMT who is in this study.
- If you have CMT1A type, you must have a specific gene change (PMP22 duplication) or a close relative with it.
- You must not have neuropathy from other causes like chemotherapy, diabetes, or alcoholism.
- You must be willing to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with certain types of Charcot-Marie-Tooth disease (CMT), a genetic nerve disorder, over time to understand how the condition progresses. It also includes healthy volunteers as controls, and no experimental treatments are given.
This study looks at how Charcot-Marie-Tooth disease (CMT) or related inherited nerve conditions change over time. It may help researchers better understand what to expect and guide future treatments.
This study follows people who have Charcot-Marie-Tooth disease (CMT) and compares them with people without it. It aims to better understand CMT, using both clinical symptoms and genetic test results, which may help future care.
This study looks at how nerves work and their structure in people with Charcot-Marie-Tooth disease, CIDP, or anti-MAG neuropathy. It may help doctors better understand these conditions.
This trial looks for new markers of Charcot-Marie-Tooth 1A (CMT1A) early in the disease. Researchers hope to find signs that can help diagnose and track the disease better, which could lead to better treatments in the future.
This study examines how autonomic nerves (the nerves that control automatic body functions like heart rate and blood pressure) are affected in people with CMT (Charcot-Marie-Tooth disease), a genetic nerve disorder. Understanding this may help improve treatment and quality of life for CMT patients.
Hear when a new Charcot-Marie-Tooth Disease, Type Ia (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.